Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout

10% Off Selected ADCs & Isotype Controls from ichorbio

ichorbio's newest discount in collaboration with 2BScientific

Save 10% on ichorbio ADCs & Isotype Controls

Order from our selected range of ichorbio antibody-drug conjugates (ADCs) and isotype controls and receive 10% off your purchase.

Terms and Conditions

  • Add any eligible IchorBio ADC or isotype control listed below to your order and receive a 10% discount from 2BScientific.
  • Offer is valid until 30th September 2026.
  • This offer cannot be used in conjunction with any other promotion or discount.
  • Custom products are excluded from this offer.
  • To redeem this offer, please contact our sales team with the products you would like to purchase, and we'll provide you with a bespoke quotation including the discount.

Antibody Drug Conjugate Biosimilars

ichorbio's portfolio of research-grade ADC biosimilars offers high-purity alternatives for your oncology and targeted therapy assays.

SKUBiosimilar BaseConjugate
ICH4014Ado-TrastuzumabEmtansine
ICH4013DTrastuzumabDeruxtecan
ICH5206DPatritumabDeruxtecan
ICH5217DDatopotamabDeruxtecan
ICH5204DIfinatamabDeruxtecan
ICH5070VEnfortumabVedotin
ICH5137VBrentuximabVedotin
ICH6017VSonesitatugVedotin

Matched Isotype Controls

Ensure accurate baseline data with our heavily characterized Human IgG1 Kappa isotype controls, available with standard and mutated backbones

Standard Human IgG1 Kappa Controls

SKUConjugateDrug-to-Antibody Ratio
ICH2254-D4
Deruxtecan
DAR4
ICH2254-D8
DeruxtecanDAR8
ICH2254-M4
MMAE (PEG8)
DAR4
ICH2254-vM4
VcMMAE
DAR4

K214R Mutated Controls

SKUConjugateDrug-to-Antibody Ratio
ICH2254KR-D4
Deruxtecan
DAR4
ICH2254KR-D8
DeruxtecanDAR8
ICH2254KR-M4
VcMMAE
DAR4

LALAPG Mutated Controls

SKUConjugateDrug-to-Antibody Ratio
ICH2254LALAPG-D8
Deruxtecan
DAR8
ICH2254LALAPG-M4
MMAE (PEG8)
DAR4
ICH2254LALAPG-VM4
VcMMAE
DAR4